Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with ...
Seeking Alpha

Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance

Includes a one-time $1.35 billion Acquired In-Process R&D charge related to the in-licensing agreement with 3SBio, Inc. recorded in the third quarter of 2025 with an unfavorable impact of ...
Nasdaq

Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance

Second-quarter 2024 Cost of Sales(4) as a percentage of revenues was relatively flat compared with the prior-year quarter, and reflects favorable changes in sales mix, primarily driven by lower sales ...
Fierce Biotech

Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out

As pharmas like Eli Lilly and Roche bolster their biotech offerings, Pfizer is snuffing out its program designed to incubate new innovations from select companies, dubbed Pfizer Ignite. | As pharmas ...

Should You Avoid Pfizer? Here's the Key Risk to Watch

Pfizer has reached a turning point.
Seeking Alpha

Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance

Includes a one-time $1.35 billion Acquired In-Process R&D charge related to the licensing agreement with 3SBio, Inc. that will be recorded in the third quarter of 2025 with an expected unfavorable ...